Serum amyloid A kinetics predicts outcomes to PD-1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.

Although the difference between the combined model and the SAA kinetics model at 12 months did not reach statistical significance, the p value was borderline (0.051), suggesting a strong trend toward improved prediction.

also in 5,725 other papers